Guido Hartmann
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia.
Journal: PloS one
Published: October 02, 2020
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
Journal: EMBO molecular medicine
Published: May 02, 2019
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
Journal: EMBO molecular medicine
Published: May 24, 2017
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
Journal: EMBO molecular medicine
Published: October 16, 2016
LYSOPHOSPHATIDIC ACIDS AND AUTOTAXIN IN RETINAL VEIN OCCLUSION.
Journal: Retina (Philadelphia, Pa.)
Published: September 21, 2016
Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 25, 2015
Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease.
Journal: The American journal of pathology
Published: August 29, 2014
Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming.
Journal: Annals of the rheumatic diseases
Published: December 05, 2013
Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds.
Journal: Journal of medicinal chemistry
Published: November 15, 2013
From acute injury to chronic disease: pathophysiological hypothesis of an epithelial/mesenchymal crosstalk alteration in CKD.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 13, 2012
Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 27, 2012
Last Updated: 09/26/2026